Aug 01, 2022 9:56am EDT Todos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by Tollovid
Jul 28, 2022 7:30am EDT Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
Jul 22, 2022 9:33am EDT Todos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary Supplementation
Jun 30, 2022 7:51am EDT Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients
Jun 23, 2022 7:00am EDT Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID
Jun 21, 2022 1:00pm EDT Todos Medical Retains Moneta Advisory Partners as Strategic Advisors for National Exchange Listing and 3CL Pharma Spinoff
Jun 13, 2022 7:45am EDT Todos Medical Completes Validation of 27 Pathogen UTI PCR Panel at Its CLIA/CAP Laboratory Provista Diagnostics
Jun 07, 2022 10:36am EDT Todos Medical Reports Day 28 Update for Case Study #5 with Erectile Dysfunction
